CorMedix (CRMD) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $14.00 from $13.00 | Aug 14, 2026 |
| RBC Capital | Maintained | Outperform | $13.00 from $14.00 | Jul 7, 2026 |
| Leerink Partners | Maintained | Outperform | $14.00 from $13.00 | Apr 28, 2026 |
| RBC Capital | Maintained | Outperform | $14.00 from $13.00 | Apr 28, 2026 |
| Citizens | Maintained | Market Outperform | $19.00 | Apr 28, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Apr 27, 2026 |
| Needham | Maintained | Buy | $15.00 from $14.00 | Apr 27, 2026 |
| Needham | Maintained | Buy | $14.00 from $15.00 | Mar 5, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Feb 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 from $18.00 | Jan 23, 2026 |
| RBC Capital | Maintained | Outperform | $13.00 from $22.00 | Jan 21, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Jan 8, 2026 |
| Needham | Maintained | Buy | $15.00 from $16.00 | Jan 8, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Dec 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 from $17.00 | Nov 13, 2025 |
| Needham | Maintained | Buy | $16.00 from $20.00 | Nov 12, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Nov 12, 2025 |
| RBC Capital | Maintained | Outperform | $22.00 from $21.00 | Oct 21, 2025 |
| D. Boral Capital | Upgraded | Hold → Buy | $14.00 | Oct 20, 2025 |
| JMP Securities | Maintained | Market Outperform | $22.00 | Sep 9, 2025 |
Frequently asked questions
Is CRMD a buy, sell, or hold?
Analysts covering CorMedix currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on CRMD?
On Aug 14, 2026, RBC Capital maintained CorMedix at Outperform with a price target of $14.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.